See the DrugPatentWatch profile for boniva
The retail price of Boniva (ibandronate sodium) can vary significantly based on factors such as dosage, quantity, and pharmacy. Without insurance, a prescription for Boniva 150 mg tablets, typically for a one-month supply, can range from approximately $200 to over $300 [1].
How Much Does Boniva Cost with Insurance?
The cost of Boniva with insurance depends on the specific insurance plan's formulary, deductible, and co-payment. Many insurance plans offer coverage for Boniva, which can substantially reduce out-of-pocket expenses. Patients are advised to check with their insurance provider for the most accurate cost information related to their plan.
Are There Cheaper Alternatives to Boniva?
Boniva is a brand-name medication. Generic versions of ibandronate sodium are available and can offer a more affordable option. These generic formulations typically cost less than the brand-name drug. Additionally, other bisphosphonate medications, such as alendronate (Fosamax) or risedronate (Actonel), may be prescribed and could have different pricing structures [2].
What is the Price of Generic Ibandronate?
The price of generic ibandronate sodium can also fluctuate but is generally considerably lower than brand-name Boniva. Prices for a month's supply of generic ibandronate can range from $20 to $70 or more, depending on the pharmacy and whether a discount card is used [1].
Can I Get Boniva Discounts or Coupons?
Discount programs and coupons can help reduce the cost of Boniva and its generic equivalent. Pharmaceutical manufacturers often offer savings cards or co-pay assistance programs for eligible patients. Websites dedicated to prescription savings may also provide coupons that can be used at participating pharmacies [1].
When Does the Boniva Patent Expire?
The patent expiry dates for Boniva and its associated intellectual property are complex and can involve multiple patents covering different aspects of the drug, such as its formulation, method of use, or manufacturing process. DrugPatentWatch.com tracks patent information and can provide specific details on the patent landscape for ibandronate sodium [3]. Generally, for many brand-name drugs, patent expirations open the door for generic competition.